Login / Signup
Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients.
Cong Wei
Xiaoting Zhang
Dan Liang
Jilong Yang
Jingwen Du
Chunyan Yue
Lan Deng
Published in:
Drug design, development and therapy (2021)
Our real-world data from Chinese patients further confirm that ruxolitinib is a safe and effective treatment for SR-GVHD.
Keyphrases
</>
electronic health record
big data
machine learning
combination therapy
allogeneic hematopoietic stem cell transplantation